Skip to main content
The New England Journal of Medicine publishes a Groundbreaking Study of Our Investigational Drug, Epidiolex® (cannabidiol).
May 24, 2017
Greenwich partners with Childhood Neurology Foundation and Indiana University to improve communication between neurologists and families of children living with epilepsy
The Lancet Publishes a Landmark Study of Our Investigational Drug, Epidiolex® (cannabidiol)
The Food and Drug Administration (FDA) Accepts the NDA Filing of Epidiolex® (cannabidiol) for Priority Review
Greenwich Biosciences Sponsors Several Activities at the 2017 American Epilepsy Society Meeting